Genentech pioneered the biotech industry and revolutionized how we treat some of the world’s most complex health problems. Today, as a member of the Roche Group, we remain dedicated to pursuing breakthrough research, developing life-changing medicines, and unlocking advances in data and technology. Roche is a leading healthcare company, heavily investing in R&D to develop differentiated treatment options in oncology, immunology, cardiovascular, renal and metabolic disease, and neurology. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche a pioneer in tailoring medical solutions to individual needs. Our Pharma Partnering team provides comprehensive BD and alliance management support for Roche and Genentech's R&D engines and the broader pharmaceutical division, with external innovation playing a critical role in our R&D strategy. In 2024, we entered into more than 70 new partnerships and managed over 250 alliances worldwide.